Home · Reading room · Before surgery

Before surgery

Endometriosis surgery while you’re on a GLP-1: what your surgical team needs to know

Laparoscopy is part of many endo journeys. A weekly injection changes one thing about it, and that thing belongs in your pre-op paperwork.

Havelle editorial · Education only, not medical advice · Reviewed October 2026

For a lot of people with endometriosis, surgery is not a hypothetical. Laparoscopy is how the disease is often confirmed, and excision or other surgical treatment is part of many care plans. If you are also on a GLP-1 medication for weight or metabolic health, there is one detail your surgical team must hear from you, and it is easy to leave off a form.

This guide covers why it matters, what current guidance says in general terms, and who makes the call. It does not tell you what to do with your dose. That decision belongs to the clinicians running your surgery.

Why anesthesia teams ask about GLP-1s

GLP-1 medications, including tirzepatide, slow how quickly the stomach empties. That is part of how they work. Under general anesthesia, food or liquid still sitting in the stomach can raise the risk of aspiration, which is why fasting rules exist in the first place. A medication that keeps the stomach fuller for longer is something the anesthesia team needs to plan around.

None of this is unique to endometriosis. It applies to anyone on a GLP-1 who is having a procedure under anesthesia. It simply matters more often for people whose care plan includes surgery.

What changed in the guidance

In 2023, early anesthesia advice suggested holding a weekly GLP-1 for a week before elective surgery. In October 2024, five medical and surgical societies, including the American Society of Anesthesiologists, published joint guidance that moved away from that default. In broad terms, it says most people can continue their GLP-1 before elective surgery, with individual risk reviewed first. For those at higher risk of stomach-emptying problems, it suggests steps such as a liquid-only diet for the 24 hours before the procedure, and in some cases an ultrasound of the stomach on the day.

The people the guidance treats as higher risk include those who are still increasing their dose and those who already have gastrointestinal symptoms such as nausea, bloating or constipation. That second group is worth noticing. Many people with endometriosis live with exactly those symptoms, so your team may reasonably treat you as higher risk even on a steady dose.

The point is not to stop or keep your medication on your own. The point is that the people putting you to sleep should never be surprised by it.

What to tell your surgical and anesthesia team

Then ask them directly: “Do you want me to change anything about my GLP-1 or my diet before this procedure?” Write down the answer and pass it to your GLP-1 provider.

What to tell your GLP-1 provider

Tell them the date of the surgery as soon as you have it. A provider who is paying attention will avoid scheduling a dose increase in the weeks around it, will follow whatever the surgical team asks for, and will help you restart smoothly afterward if your dose was paused. Recovery from laparoscopy often brings its own nausea and bowel changes, so a dose step-up the same week makes it much harder to know what is causing what.

This is the kind of coordination the Whole-Woman Charter is built to measure: a provider who reads your whole history, titrates to how you are actually doing, and is reachable when your plans change. Our guide to telling a side effect from a flare is a useful companion for the weeks after surgery.

The line we hold everywhere. GLP-1 medications are not a treatment for endometriosis, and nothing here suggests they change what surgery finds or how it goes. Decisions about your dose before and after a procedure belong to your surgical, anesthesia and prescribing teams. Nothing here is medical advice.

Five questions to ask any GLP-1 provider →